1. Home
  2. PFE vs ABT Comparison

PFE vs ABT Comparison

Compare PFE & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pfizer Inc.

PFE

Pfizer Inc.

HOLD

Current Price

$27.15

Market Cap

155.2B

Sector

Health Care

ML Signal

HOLD

ABT

Abbott Laboratories

HOLD

Current Price

$111.31

Market Cap

189.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PFE
ABT
Founded
1849
1888
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
155.2B
189.6B
IPO Year
2013
2006

Fundamental Metrics

Financial Performance
Metric
PFE
ABT
Price
$27.15
$111.31
Analyst Decision
Hold
Strong Buy
Analyst Count
12
16
Target Price
$27.83
$139.38
AVG Volume (30 Days)
29.3M
6.4M
Earning Date
05-04-2026
04-23-2026
Dividend Yield
6.32%
2.26%
EPS Growth
N/A
N/A
EPS
1.36
3.72
Revenue
$62,579,000,000.00
$44,328,000,000.00
Revenue This Year
N/A
$8.92
Revenue Next Year
N/A
$7.39
P/E Ratio
$19.99
$29.96
Revenue Growth
N/A
5.67
52 Week Low
$20.92
$105.27
52 Week High
$27.94
$137.49

Technical Indicators

Market Signals
Indicator
PFE
ABT
Relative Strength Index (RSI) 54.45 47.71
Support Level $23.83 $111.18
Resistance Level $27.67 $113.76
Average True Range (ATR) 0.52 1.93
MACD -0.05 -0.14
Stochastic Oscillator 67.33 41.03

Price Performance

Historical Comparison
PFE
ABT

About PFE Pfizer Inc.

Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.

About ABT Abbott Laboratories

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.

Share on Social Networks: